Vanguard Personalized Indexing Management LLC Purchases 9,674 Shares of Intuitive Surgical, Inc. $ISRG

Vanguard Personalized Indexing Management LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 57,477 shares of the medical equipment provider’s stock after acquiring an additional 9,674 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Intuitive Surgical were worth $31,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Oak Ridge Investments LLC grew its holdings in shares of Intuitive Surgical by 1.7% in the second quarter. Oak Ridge Investments LLC now owns 18,508 shares of the medical equipment provider’s stock worth $10,057,000 after acquiring an additional 311 shares during the period. Concurrent Investment Advisors LLC grew its holdings in shares of Intuitive Surgical by 35.3% in the second quarter. Concurrent Investment Advisors LLC now owns 17,787 shares of the medical equipment provider’s stock worth $9,666,000 after acquiring an additional 4,637 shares during the period. Johnson Investment Counsel Inc. grew its holdings in shares of Intuitive Surgical by 3.2% in the second quarter. Johnson Investment Counsel Inc. now owns 29,042 shares of the medical equipment provider’s stock worth $15,782,000 after acquiring an additional 898 shares during the period. 1858 Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 2.8% in the second quarter. 1858 Wealth Management LLC now owns 3,614 shares of the medical equipment provider’s stock worth $1,964,000 after acquiring an additional 98 shares during the period. Finally, Apollon Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 47.6% in the second quarter. Apollon Wealth Management LLC now owns 24,883 shares of the medical equipment provider’s stock worth $13,522,000 after acquiring an additional 8,029 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 3.2%

Shares of Intuitive Surgical stock opened at $429.59 on Friday. The stock’s 50-day simple moving average is $458.68 and its 200-day simple moving average is $497.91. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market capitalization of $154.00 billion, a price-to-earnings ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the business earned $1.78 earnings per share. The business’s revenue was up 21.4% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts recently commented on ISRG shares. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday. BTIG Research reiterated a “buy” rating and set a $571.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.